Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 295: 122579, 2023 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-36898324

RESUMEN

Herein, we describe the synthesis of a new fluorescent d10 coordination polymer, [Zn2(CFDA)2(BPEP)]n·nDMF (CP-1) under solvothermal reaction condition using zinc metal ion. In CP-1, Zn(II) ion along with CFDA and BPED ligand forms a 2-fold self-interpenetrated 3D coordination polymers. This CP-1 is characterized by the single crystal X-ray diffraction (SCXRD), powder X-ray diffraction (PXRD), infrared spectra, optical microscope image and thermogravimetric analysis and the framework is found to maintain its structural stability in different solvents. The framework (CP-1) detected antibiotics (NFT (nitrofurantoin) and NZF (nitrofurazone)) and organo-toxin trinitrophenol in aqueous dispersed medium. Apart from the fast responsive (10 s), the detection limit for them was found at ppb level. The detection of these organo-aromatics were also comprehended by the colorimetric response through solid, solution and low cost paper strip technique i.e., triple mode recognition capability. The probe is re-usable without changing in its sensing efficiency and in addition, it has been applied for the detection of these analytes in the real field specimens (soil, river water, human urine and commercial tablet). The sensing ability is established by in-depth experimental analysis and the life time measurement where mechanism such as photo induced electron transfer (PET), fluorescence resonance energy transfer (FRET), inner filter effect (IFE) was recognized. The presence of guest interaction sites on the linker backbone in CP-1 induces diverse supramolecular interaction with the targeted analytes results to bring them in proximity for the occurrence of these sensing mechanism. The Stern-Volmer quenching constant values of CP-1 for the targeted analytes are admirable and the low detection limit (LOD) values for NFT, NZF and TNP are found to be 34.54, 67.79 and 43.93 ppb respectively. Further, the DFT theory is carried out in details to justify the sensing mechanism.

2.
Inorg Chem ; 61(2): 939-943, 2022 Jan 17.
Artículo en Inglés | MEDLINE | ID: mdl-34974708

RESUMEN

The single-crystal X-ray diffraction method was employed to characterize a rigid hydrated metal-organic framework (MOF), [Co2(MA)(INA)·2H2O]n, that displays an affinity toward water molecules under ambient conditions after dehydration. The fully dehydrated form was obtained using an environmental gas cell technique in a stepwise manner followed by its CO2-pressurized structure at 298 K using in situ crystallography.

3.
Indian J Pathol Microbiol ; 56(2): 135-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24056650

RESUMEN

BACKGROUND: AmpC beta lactamases are cephalosporinases that confer resistance to a wide range of beta lactam drugs thereby causing serious therapeautic problem. As there are no CLSI guidelines for detection of AmpC mediated resistance in Gram negative clinical isolates and it may pose a problem due to misleading results, especially so in phenotypic tests. Although cefoxitin resistance is used as a screening test, it does not reliably indicate AmpC production. MATERIALS AND METHODS: We planned a study to determine the occurrence of AmpC beta lactamase in hospital and community, clinical isolates of Escherichia coli and simultaneously evaluate different phenotypic methods for detection of AmpC beta lactamases. RESULTS: It was observed that 82.76% isolates were ESBL positive and 59% were cefoxitin screen positive. Using phenotypic confirmatory tests the occurrence of Amp C beta lactamases was found to be 40% and 39% by inhibitor based method using boronic acid (IBM) and modified three dimensional test (M3D) respectively. CONCLUSION: Both the test showed concordant result. Co-production was observed in 84.62% isolates Screening of ESBL and Amp C can be done in routine clinical microbiology laboratory using aztreonam and IBM respectively as it is a simple, rapid and technically less demanding procedure which can be used in all clinical laboratories.


Asunto(s)
Proteínas Bacterianas/metabolismo , Escherichia coli/enzimología , beta-Lactamasas/metabolismo , Antibacterianos/farmacología , Infecciones Comunitarias Adquiridas/microbiología , Infección Hospitalaria/microbiología , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/microbiología , Humanos , Pruebas de Sensibilidad Microbiana/métodos , beta-Lactamas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA